Clinical Trials on Hepatic Veno-Occlusive Disease

Total 11527 results

Vertex Pharmaceuticals Incorporated

Completed

Study of Telaprevir in Subjects With Hepatic Impairment

Hepatic Insufficiency

United States
University Hospital Heidelberg

Recruiting

Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases (MAESTRO)

Hepatic Metastasis

Germany
Aga Khan University

Unknown

Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage

Encephalopathy, Hepatic | Hepatocerebral Encephalopathy | Portal-Systemic Encephalopathy | Encephalopathy, Hepatocerebral

Pakistan
University Hospital, Grenoble

Recruiting

Description of Lactulose Administration by Balloon Rectal Tube in Severe Hepatic Encephalopathy (ALPACA)

Hepatic Encephalopathy

France
University of Michigan
Winterlight Labs

Active, not recruiting

Speech in Hepatic Encephalopathy (HE)

Hepatic Encephalopathy

United States
Abbott

Completed

A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]

Hepatic Encephalopathy

India
Assiut University

Unknown

Plasma Free Amino Acids in Patients With Hepatic Encephalopathy

Hepatic Encephalopathy
Abbott
Dimension Research

Completed

Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan (Preempt)

Hepatic Encephalopathy

Pakistan
Sherief Abd-Elsalam

Unknown

PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy

Hepatic Encephalopathy

Egypt
Ain Shams University
Al-Azhar University

Unknown

The Effects of Nitazoxanide in Hepatic Encephalopathy

Hepatic Encephalopathy

Egypt
Hunter Holmes Mcguire Veteran Affairs Medical Center

Completed

A Study of Controlled Lactulose Withdrawal

Hepatic Encephalopathy

United States
Govind Ballabh Pant Hospital

Unknown

Trial Comparing Sedation for Endoscopy With Propofol Versus Midazolam in Cirrhotics

Hepatic Encephalopathy

India
University of California, Los Angeles

Recruiting

Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure

Cardiovascular Diseases | Atherosclerosis | Arterial Occlusion | Hematoma

United States
Eli Lilly and Company

Recruiting

A Study of LY3437943 in Participants With Impaired and Normal Liver Function

Hepatic Insufficiency | Healthy

United States
PharmaMar

Recruiting

Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment

Hepatic Impairment | Advanced Solid Tumor

Spain
Incyte Corporation

Completed

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

Advanced Malignancies

United States
Loma Linda University

Completed

Hepatitis C Virus (HCV) Positive Liver Grafts in HCV Negative Recipients

Liver Failure

United States
Boehringer Ingelheim

Completed

A Study to Test How Different Doses of BI 685509 Are Tolerated in Patients With Liver Problems

Hepatic Insufficiency | Healthy

United States
Tongji Hospital

Unknown

A Study on Nutrition Support Therapy of Patients With Liver Failure

Nutrition
Universidad de Extremadura
Complejo Hospitalario Universitario de Badajoz

Unknown

Jaundice as Initial Presentation of Liver Hydatidosis (ICTEHIDA) (ICTEHIDA)

Jaundice | Hepatic Echinococcosis

Spain
Pauls Stradins Clinical University Hospital

Active, not recruiting

Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold Implantation (CTO_BVS)

Coronary Artery Disease | Angina Pectoris | Occlusion, Coronary

Latvia
Beijing Anzhen Hospital

Enrolling by invitation

Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Drug-Eluting Stents

China
Al-Azhar University

Not yet recruiting

Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy

Hepatic Encephalopathy

Egypt
National Hepatology & Tropical Medicine Research...

Not yet recruiting

Vegetable Proteins Versus Mixed Animal Proteins on the Outcome of Hepatic Encephalopathy

Hepatic Encephalopathy

Egypt
The Cleveland Clinic

Recruiting

Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

Hepatic Encephalopathy

United States
Massachusetts General Hospital
Center for Microbiome Informatics and Therapeutics

Active, not recruiting

Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy

Hepatic Encephalopathy

United States
Bausch Health Americas, Inc.

Completed

A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy

Hepatic Encephalopathy
Bausch Health Americas, Inc.

Completed

Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy

Hepatic Encephalopathy

United States, Canada
Horizon Pharma Ireland, Ltd., Dublin Ireland

Terminated

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Hepatic Encephalopathy

United States
University of Aarhus

Unknown

Quantitative Determination of Brain Water Content in Patients During and After Hepatic Encepalopathy

Hepatic Encephalopathy

Denmark
Institute of Liver and Biliary Sciences, India

Completed

Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial

Hepatic Encephalopathy

India
Ono Pharma USA Inc
Ono Pharmaceutical Co. Ltd

Completed

An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment

Healthy | Hepatic Impairment

United States
Alnylam Pharmaceuticals

Terminated

INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

Acute Hepatic Porphyria | Acute Intermittent Porphyria (AIP) | Hereditary Coproporphyria (HCP) | Variegate Porphyria (VP) | ALA Dehydratase Deficient Porphyria (ADP) | Hepatic Porphyrias | Porphyria Acute

United States
Khyber Medical College, Peshawar

Not yet recruiting

Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy

Hepatic Encephalopathy | Chronic Liver Disease
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Hepatic Encephalopathy

United States
Ain Shams University

Recruiting

Efficacy of L-Ornithine L-Aspartate (LOLA) as an Adjunct to Branched Chain Amino Acids (BCAA) Enriched Solutions on Clinical Outcomes in ICU Patients With Hepatic Encephalopathy

Hepatic Encephalopathy

Egypt
University Hospital, Toulouse
Société nationale française de gastro-entérologie

Recruiting

Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study (POEME) (POEME)

Hepatic Encephalopathy

France
Duke University

Recruiting

Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy

Hepatic Encephalopathy

United States
Mayo Clinic

Completed

Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration

Hepatic Encephalopathy

United States
University of Alberta
Rebiotix Inc.

Completed

Fecal Transplant for Hepatic Encephalopathy

Hepatic Encephalopathy

Canada
University of Alberta

Completed

Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study

Hepatic Encephalopathy

Canada
Mahidol University

Completed

Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy

Hepatic Encephalopathy

Thailand
Norgine

Completed

Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER) (PROSPER)

Hepatic Encephalopathy

United Kingdom
NYU Langone Health
Bausch Health Americas, Inc.

Terminated

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.

Hepatic Encephalopathy

United States
Ocera Therapeutics

Completed

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy (AST015)

Hepatic Encephalopathy

United States
Hartford Hospital

Recruiting

Liposomal Bupivacaine/Bupivacaine in RS Blocks vs. Ropivacaine in RS Blocks And Catheters (EXODUS)

Aortic Aneurysm, Abdominal | Aortic Diseases | Aortoiliac Occlusive Disease | Abdominal Aortic Occlusion

United States
Eli Lilly and Company

Completed

A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function

Hepatic Insufficiency | Healthy

United States
Daiichi Sankyo, Inc.
Medpace, Inc.

Completed

Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment

Cancer | Solid Tumor | Hepatic Impairment

United States
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)

Hepatic Insufficiency | Insomnia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function

Hepatic Insufficiency | Healthy

United States

3

Subscribe